To study the effect of Dadimadi Churna in the management of Peenasa
Phase 2
- Conditions
- Health Condition 1: J069- Acute upper respiratory infection,unspecified
- Registration Number
- CTRI/2023/01/048840
- Lead Sponsor
- Dr. Saurabh Mhaske
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
The patients having at least 2 â?? 3 symptoms of Peenasa are as follows-
Nasastrava,Frequency of Kshavathu ,Nasavarodha, Nasakandu and Shirashoola.The patients of age from 3 year to 12 years.
The patients who separents are ready to participate in the clinical trial by giving informed written consent.
Exclusion Criteria
Patients and his/her parents/guardian not willing for trial.Patients having life threatening illness and who is bedridden.Patient who need surgical and other intervention.Patients presenting with symptoms of Dushta Peenasa/ Pratishyaya and Raktaga.Patients suffering with other Nasal diseases like Nasal Polyps, Nasal Septum
Patients associated with Nasal Malignancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in the symptoms of PeenasaTimepoint: 7 day study , 0th,3rd ,7th day
- Secondary Outcome Measures
Name Time Method To observe the adverse effect of Dadimadi ChurnaTimepoint: 7 day study , 0th,3rd ,7th day